DK1974058T3 - Genekspressionsmarkører til prognosticering af kolorektal cancer - Google Patents
Genekspressionsmarkører til prognosticering af kolorektal cancerInfo
- Publication number
- DK1974058T3 DK1974058T3 DK07717900.0T DK07717900T DK1974058T3 DK 1974058 T3 DK1974058 T3 DK 1974058T3 DK 07717900 T DK07717900 T DK 07717900T DK 1974058 T3 DK1974058 T3 DK 1974058T3
- Authority
- DK
- Denmark
- Prior art keywords
- prognostication
- gene expression
- colorectal cancer
- expression markers
- markers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57446—Specifically defined cancers of stomach or intestine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75839206P | 2006-01-11 | 2006-01-11 | |
| US80027706P | 2006-05-12 | 2006-05-12 | |
| US81007706P | 2006-05-31 | 2006-05-31 | |
| PCT/US2007/000995 WO2007082099A2 (en) | 2006-01-11 | 2007-01-11 | Gene expression markers for colorectal cancer prognosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1974058T3 true DK1974058T3 (da) | 2014-09-01 |
Family
ID=38257063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07717900.0T DK1974058T3 (da) | 2006-01-11 | 2007-01-11 | Genekspressionsmarkører til prognosticering af kolorektal cancer |
Country Status (15)
| Country | Link |
|---|---|
| US (10) | US7695913B2 (da) |
| EP (9) | EP2377950B1 (da) |
| JP (7) | JP5297202B2 (da) |
| KR (1) | KR20090003178A (da) |
| AU (1) | AU2007204826B2 (da) |
| BR (1) | BRPI0706511A2 (da) |
| CA (1) | CA2636984A1 (da) |
| DK (1) | DK1974058T3 (da) |
| ES (1) | ES2491222T3 (da) |
| HK (1) | HK1120089A1 (da) |
| IL (1) | IL192794A (da) |
| MX (1) | MX2008008973A (da) |
| NO (1) | NO20083461L (da) |
| NZ (7) | NZ593228A (da) |
| WO (1) | WO2007082099A2 (da) |
Families Citing this family (74)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2506066A1 (en) | 2002-11-15 | 2004-06-03 | Genomic Health, Inc. | Gene expression profiling of egfr positive cancer |
| CA2563074C (en) | 2004-04-09 | 2014-05-20 | Genomic Health, Inc. | Gene expression markers for predicting response to chemotherapy |
| EP2377950B1 (en) * | 2006-01-11 | 2014-09-17 | Genomic Health, Inc. | Gene expression markers for colorectal cancer prognosis |
| US8700335B2 (en) | 2006-05-18 | 2014-04-15 | Caris Mpi, Inc. | System and method for determining individualized medical intervention for a disease state |
| US8768629B2 (en) * | 2009-02-11 | 2014-07-01 | Caris Mpi, Inc. | Molecular profiling of tumors |
| US20090076734A1 (en) | 2007-03-22 | 2009-03-19 | Torres-Roca Javier F | Gene Signature for the Prediction of Radiation Therapy Response |
| US20080234946A1 (en) * | 2007-03-22 | 2008-09-25 | University Of South Florida | Predictive radiosensitivity network model |
| PL2140269T3 (pl) | 2007-03-27 | 2014-07-31 | Immunovia Ab | Podpis białkowy/znaczniki do wykrywania gruczolakoraka |
| US20090123920A1 (en) * | 2007-11-08 | 2009-05-14 | Maher Albitar | Jak2 mutations |
| ES2332167B1 (es) | 2007-12-04 | 2010-10-25 | Universidad Autonoma De Madrid | Empleo de trefoil factor-family 3 (tff3) en el pronostico de sujetos diagnosticados con cancer colorectal. |
| WO2009123634A1 (en) * | 2008-04-02 | 2009-10-08 | Regents Of The University Of California | Systems and methods for predicting response of biological samples |
| US8067178B2 (en) | 2008-03-14 | 2011-11-29 | Genomic Health, Inc. | Gene expression markers for prediction of patient response to chemotherapy |
| NZ610482A (en) | 2008-05-14 | 2014-08-29 | Genomic Health Inc | Predictors of patient response to treatment with egf receptor inhibitors |
| US20100029748A1 (en) * | 2008-08-04 | 2010-02-04 | Sloan-Kettering Institute For Cancer Research | Metastasis Promoting Genes and Proteins |
| US10359425B2 (en) * | 2008-09-09 | 2019-07-23 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
| US20100221752A2 (en) * | 2008-10-06 | 2010-09-02 | Somalogic, Inc. | Ovarian Cancer Biomarkers and Uses Thereof |
| US20110257034A1 (en) * | 2008-10-10 | 2011-10-20 | Cornell University | Methods for identifying genes which predict disease outcome for patients with colon cancer |
| US20120041274A1 (en) | 2010-01-07 | 2012-02-16 | Myriad Genetics, Incorporated | Cancer biomarkers |
| US8765383B2 (en) * | 2009-04-07 | 2014-07-01 | Genomic Health, Inc. | Methods of predicting cancer risk using gene expression in premalignant tissue |
| EP2425020A4 (en) * | 2009-05-01 | 2016-04-20 | Genomic Health Inc | GENE EXPRESSION PROFILE ALGORITHM AND COLORECTAL CANCER RECURRENCE PROBABILITY ANALYSIS AND RESPONSE TO CHEMOTHERAPY |
| TWI513465B (zh) * | 2009-06-25 | 2015-12-21 | Regeneron Pharma | 以ｄｌｌ４拮抗劑與化學治療劑治療癌症之方法 |
| US20120053253A1 (en) | 2010-07-07 | 2012-03-01 | Myriad Genetics, Incorporated | Gene signatures for cancer prognosis |
| US20130116150A1 (en) | 2010-07-09 | 2013-05-09 | Somalogic, Inc. | Lung Cancer Biomarkers and Uses Thereof |
| WO2012015765A2 (en) | 2010-07-27 | 2012-02-02 | Genomic Health, Inc. | Method for using gene expression to determine prognosis of prostate cancer |
| CN106198980B (zh) | 2010-08-13 | 2018-09-07 | 私募蛋白质体公司 | 胰腺癌生物标记及其用途 |
| WO2012030840A2 (en) | 2010-08-30 | 2012-03-08 | Myriad Genetics, Inc. | Gene signatures for cancer diagnosis and prognosis |
| US9670547B2 (en) | 2010-09-15 | 2017-06-06 | Almac Diagnostics Limited | Molecular diagnostic test for cancer |
| JP2014509189A (ja) * | 2011-01-25 | 2014-04-17 | アルマック ダイアグノスティックス リミテッド | 結腸ガン遺伝子発現シグネチャーおよび使用方法 |
| EP2773772A1 (en) | 2011-11-04 | 2014-09-10 | Oslo Universitetssykehus HF | Methods and biomarkers for analysis of colorectal cancer |
| AU2012344155A1 (en) | 2011-11-28 | 2014-07-03 | Fundacio Institut De Recerca Biomedica (Irb Barcelona) | Methods and kits for the prognosis of colorectal cancer |
| EP2794924B1 (en) | 2011-12-22 | 2019-02-06 | Baylor Research Institute | Identification of mirna signatures in human colorectal cancer |
| CA2860594A1 (en) * | 2012-01-09 | 2013-07-18 | Oslo Universitetssykehus Hf | Methods and biomarkers for analysis of colorectal cancer |
| NZ722902A (en) | 2012-01-31 | 2017-12-22 | Genomic Health Inc | Gene expression profile algorithm and test for determining prognosis of prostate cancer |
| WO2013150167A2 (es) | 2012-04-03 | 2013-10-10 | Servicio Andaluz De Salud | Modelo de expresión de microarn como indicador de supervivencia en pacientes de cancer colorrectal metastásico |
| WO2014077915A1 (en) * | 2012-11-14 | 2014-05-22 | Mayo Foundation For Medical Education And Research | Methods and materials for identifying malignant skin lesions |
| EP4190918A1 (en) | 2012-11-16 | 2023-06-07 | Myriad Genetics, Inc. | Gene signatures for cancer prognosis |
| ES2475366B1 (es) * | 2012-12-10 | 2015-05-05 | Fundación Imdea Alimentación | Métodos y kits para el pronóstico del cáncer colorrectal |
| US20140272969A1 (en) | 2013-03-14 | 2014-09-18 | Abbott Molecular Inc. | Cell preparations and cell supports and their use in theranosis |
| AR096507A1 (es) * | 2013-05-30 | 2016-01-13 | Fundació Institució Catalana De Recerca I Estudis Avançats | Métodos y kits para el pronóstico del cáncer colorrectal |
| US10185809B1 (en) * | 2013-10-15 | 2019-01-22 | Iqvia Inc. | Patient projection methodology |
| GB201319878D0 (en) * | 2013-11-11 | 2013-12-25 | Immunovia Ab | Method, Array and use thereof |
| AU2015237229A1 (en) * | 2014-03-28 | 2016-11-10 | Applied Proteomics, Inc. | Protein biomarker profiles for detecting colorectal tumors |
| EP3623482A1 (en) | 2014-05-13 | 2020-03-18 | Myriad Genetics, Inc. | Gene signatures for cancer prognosis |
| WO2016025717A1 (en) | 2014-08-14 | 2016-02-18 | Mayo Foundation For Medical Education And Research | Methods and materials for identifying metastatic malignant skin lesions and treating skin cancer |
| JP6415712B2 (ja) | 2014-10-24 | 2018-10-31 | コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． | 標的遺伝子発現の数学的モデル化を用いるＴＧＦ−β細胞シグナル伝達経路活性の評価 |
| CN108064380A (zh) | 2014-10-24 | 2018-05-22 | 皇家飞利浦有限公司 | 使用多种细胞信号传导途径活性的医学预后和治疗反应的预测 |
| CA2965217A1 (en) | 2014-10-24 | 2016-04-28 | Koninklijke Philips N.V. | Medical prognosis and prediction of treatment response using multiple cellular signaling pathway activities |
| CN107002720B (zh) | 2014-11-25 | 2018-10-16 | 三菱电机株式会社 | 气压式致动器 |
| WO2016089928A1 (en) * | 2014-12-01 | 2016-06-09 | Weitz Andrew C | Methods for treating and assessing tumor invasion and metastasis |
| EP3073268A1 (en) * | 2015-03-27 | 2016-09-28 | Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts | Biomarker panel for diagnosing cancer |
| US9689874B2 (en) | 2015-04-10 | 2017-06-27 | Applied Proteomics, Inc. | Protein biomarker panels for detecting colorectal cancer and advanced adenoma |
| US11244760B2 (en) | 2015-06-25 | 2022-02-08 | Karydo Therapeutix, Inc. | Prediction device based on inter-organ cross talk system |
| AU2016309659A1 (en) | 2015-08-14 | 2018-04-12 | Koninklijke Philips N.V. | Assessment of NFkB cellular signaling pathway activity using mathematical modelling of target gene expression |
| WO2017170803A1 (ja) | 2016-03-29 | 2017-10-05 | 株式会社国際電気通信基礎技術研究所 | 医薬組成物又は食品組成物、及び有効成分の体内での効果の評価方法 |
| CN109477147A (zh) | 2016-05-10 | 2019-03-15 | 梅约医学教育与研究基金会 | 用于皮肤癌分期和治疗的方法和材料 |
| US11746381B2 (en) | 2017-03-10 | 2023-09-05 | Cancer Diagnostics Research Innvovations, LLC | Methods for diagnosing and treating gastric cancer using miRNA expression |
| WO2018224731A1 (en) * | 2017-06-05 | 2018-12-13 | Ls Cancerdiag Oy | A method for determining whether a subject is at risk to develop cancer and tools related thereto |
| EP3461915A1 (en) | 2017-10-02 | 2019-04-03 | Koninklijke Philips N.V. | Assessment of jak-stat1/2 cellular signaling pathway activity using mathematical modelling of target gene expression |
| EP3502279A1 (en) | 2017-12-20 | 2019-06-26 | Koninklijke Philips N.V. | Assessment of mapk-ap 1 cellular signaling pathway activity using mathematical modelling of target gene expression |
| JP7027179B2 (ja) * | 2018-01-24 | 2022-03-01 | キヤノン株式会社 | 給送回転体、シート給送装置及び画像形成装置 |
| US11198911B2 (en) | 2018-03-08 | 2021-12-14 | University Of Notre Dame Du Lac | Systems and methods for assessing colorectal cancer molecular subtype and risk of recurrence and for determining and administering treatment protocols based thereon |
| KR102007450B1 (ko) * | 2018-05-31 | 2019-08-05 | 한국과학기술연구원 | 대장암 치료제 발굴을 위한 신규 표적 치료 작용점의 스크리닝 방법 및 이를 이용하여 선별한 대장암 치료 예후 바이오마커 |
| WO2020112853A1 (en) | 2018-11-28 | 2020-06-04 | Genascence Corporation | Methods and compositions for treating osteoarthritis |
| WO2020123699A1 (en) * | 2018-12-11 | 2020-06-18 | The Trustees Of Columbia University In The City Of New York | Compounds and compositions that cause mycn and/or cmyc degradation and methods of use thereof |
| CN110257518B (zh) * | 2019-07-01 | 2022-08-02 | 复旦大学附属中山医院 | 一种用于预测转移性结直肠癌转化治疗疗效的基因集 |
| KR102263984B1 (ko) * | 2020-02-21 | 2021-06-11 | 재단법인 아산사회복지재단 | 직장암 환자에서 수술-전 화학방사선치료의 반응을 예측하기 위한 분석방법 |
| KR102535150B1 (ko) * | 2020-04-14 | 2023-05-23 | 주식회사 베르티스 | 암의 예후 예측용 조성물 |
| WO2021222220A2 (en) * | 2020-04-29 | 2021-11-04 | Freenome Holdings, Inc. | Rna markers and methods for identifying colon cell proliferative disorders |
| GB202010970D0 (en) | 2020-07-16 | 2020-09-02 | Immunovia Ab | Methods, arrays and uses thereof |
| CN112322730B (zh) * | 2020-10-16 | 2023-04-18 | 上海市第一人民医院 | 预测肿瘤耐药、复发的标志物kifc1及其抑制剂和应用 |
| EP4026918A1 (en) | 2021-01-12 | 2022-07-13 | Koninklijke Philips N.V. | Prediction of an outcome of a colorectal cancer subject |
| CN113667673B (zh) * | 2021-07-15 | 2024-02-06 | 武汉血液中心 | 一种类孟买血型FUT1 236delG等位基因及其检测方法和应用 |
| KR20230059642A (ko) * | 2021-10-26 | 2023-05-03 | 사회복지법인 삼성생명공익재단 | miRNA를 포함하는 대장암의 치료 및 전이 억제용 조성물 및 이의 용도 |
| WO2024035653A1 (en) * | 2022-08-06 | 2024-02-15 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Predictive biomarker in avastin in colon cancer |
Family Cites Families (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020172987A1 (en) * | 1998-02-12 | 2002-11-21 | Terstappen Leon W.M.M. | Methods and reagents for the rapid and efficient isolation of circulating cancer cells |
| WO1999064626A2 (en) | 1998-06-06 | 1999-12-16 | Genostic Pharma Limited | Probes used for genetic profiling |
| AU4158799A (en) | 1998-06-06 | 1999-12-30 | Genostic Pharma Limited | Probes used for genetic filing |
| JP5213202B2 (ja) | 1998-10-28 | 2013-06-19 | バイシス・インコーポレーテツド | 細胞アレイならびに遺伝障害マーカーの検出および使用方法 |
| EP0999016B1 (en) * | 1998-11-06 | 2001-07-11 | Temco S. R. L. | Cutter for cross cutting of webs |
| US6960439B2 (en) * | 1999-06-28 | 2005-11-01 | Source Precision Medicine, Inc. | Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles |
| US6692916B2 (en) * | 1999-06-28 | 2004-02-17 | Source Precision Medicine, Inc. | Systems and methods for characterizing a biological condition or agent using precision gene expression profiles |
| EP1265582A2 (en) * | 1999-09-29 | 2002-12-18 | Human Genome Sciences, Inc. | Colon and colon cancer associated polynucleotides and polypeptides |
| AU2088801A (en) | 1999-12-10 | 2001-06-18 | Dana-Farber Cancer Institute, Inc. | Metastasis genes and uses thereof |
| US7029677B2 (en) * | 2000-01-25 | 2006-04-18 | Nuvelo, Inc. | Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells |
| US7195870B2 (en) | 2000-04-06 | 2007-03-27 | Epigenomics Ag | Diagnosis of diseases associated with gene regulation |
| WO2005000087A2 (en) | 2003-06-03 | 2005-01-06 | Chiron Corporation | Gene products differentially expressed in cancerous colon cells and their methods of use ii |
| EP1307556A2 (en) | 2000-08-03 | 2003-05-07 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of colon cancer |
| US20030166064A1 (en) * | 2000-08-03 | 2003-09-04 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of colon cancer |
| US20020110832A1 (en) | 2000-08-03 | 2002-08-15 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of colon cancer |
| US20030077568A1 (en) * | 2000-09-15 | 2003-04-24 | Gish Kurt C. | Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
| WO2002024956A2 (en) | 2000-09-19 | 2002-03-28 | Whitehead Institute For Biomedical Research | Genetic markers for tumors |
| AU2002246519A1 (en) * | 2000-11-20 | 2002-08-06 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of colon cancer |
| WO2002074156A2 (en) * | 2001-02-02 | 2002-09-26 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of colon cancer |
| US20020197633A1 (en) * | 2001-05-09 | 2002-12-26 | Jones Brian C. | Evaluation of ultraviolet radiation damage to skin using new gene markers, methods and compositions related thereto |
| US20030148314A1 (en) * | 2001-08-01 | 2003-08-07 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of colon cancer |
| US7622260B2 (en) * | 2001-09-05 | 2009-11-24 | The Brigham And Women's Hospital, Inc. | Diagnostic and prognostic tests |
| CA2466502A1 (en) * | 2001-11-09 | 2003-05-15 | Source Precision Medicine, Inc. | Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles |
| US20030225526A1 (en) * | 2001-11-14 | 2003-12-04 | Golub Todd R. | Molecular cancer diagnosis using tumor gene expression signature |
| US20030148410A1 (en) * | 2001-12-10 | 2003-08-07 | Millennium Pharmaceuticals, Inc. | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of colon cancer |
| EP1534739A4 (en) * | 2002-01-18 | 2006-05-31 | Bristol Myers Squibb Co | IDENTIFICATION OF POLYNUCLEOTIDES AND POLYPEPTIDES FOR PREDICTING THE ACTIVITY OF COMPOUNDS THAT INTERACT WITH TYROSINE KINASE PROTEINS AND / OR TYROSINE KINASE PROTEIN PATHWAYS |
| US7955800B2 (en) * | 2002-06-25 | 2011-06-07 | Advpharma Inc. | Metastasis-associated gene profiling for identification of tumor tissue, subtyping, and prediction of prognosis of patients |
| US20040053317A1 (en) * | 2002-09-10 | 2004-03-18 | Sidney Kimmel Cancer Center | Gene segregation and biological sample classification methods |
| AU2003304203A1 (en) | 2002-10-29 | 2005-01-04 | Pharmacia Corporation | Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same |
| ATE412779T1 (de) * | 2003-02-20 | 2008-11-15 | Genomic Health Inc | Benutzung von intronischen rna sequenzen zur quantifizierung der genexpression |
| EP3330875B1 (en) | 2003-07-10 | 2021-12-01 | Genomic Health, Inc. | Expression profile algorithm and test for prognosing breast cancer recurrence |
| WO2005015236A2 (en) | 2003-07-18 | 2005-02-17 | Roche Diagnostics Gmbh | A method for predicting the progression of adenocarcinoma |
| US20050014165A1 (en) * | 2003-07-18 | 2005-01-20 | California Pacific Medical Center | Biomarker panel for colorectal cancer |
| AU2004262369A1 (en) * | 2003-07-29 | 2005-02-10 | Bristol-Myers Squibb Company | Biomarkers of cyclin-dependent kinase modulation |
| EP1892306A3 (en) | 2003-10-06 | 2008-06-11 | Bayer HealthCare AG | Methods and kits for investigating cancer |
| WO2005076005A2 (en) | 2004-01-30 | 2005-08-18 | Medizinische Universität Wien | A method for classifying a tumor cell sample based upon differential expression of at least two genes |
| US20060195266A1 (en) * | 2005-02-25 | 2006-08-31 | Yeatman Timothy J | Methods for predicting cancer outcome and gene signatures for use therein |
| WO2005100593A1 (en) | 2004-04-16 | 2005-10-27 | Monash University | A method for monitoring the progress of cancer |
| WO2006010150A2 (en) | 2004-07-15 | 2006-01-26 | University Of Utah Research Foundation | Housekeeping genes and methods for identifying the same |
| US20060183893A1 (en) | 2005-01-25 | 2006-08-17 | North Don A | Nucleic acids for apoptosis of cancer cells |
| US20090220495A1 (en) | 2005-04-07 | 2009-09-03 | Abdallah Fanidi | Cancer Related Genes (PRLR) |
| EP1907858A4 (en) * | 2005-06-13 | 2009-04-08 | Univ Michigan | COMPOSITIONS AND METHODS OF TREATMENT AND DIAGNOSIS OF CANCER |
| WO2007061876A2 (en) | 2005-11-23 | 2007-05-31 | University Of Utah Research Foundation | Methods and compositions involving intrinsic genes |
| WO2007070621A2 (en) | 2005-12-13 | 2007-06-21 | Children's Medical Center Corporation | Prognosis indicators for solid human tumors |
| NZ544432A (en) | 2005-12-23 | 2009-07-31 | Pacific Edge Biotechnology Ltd | Prognosis prediction for colorectal cancer using a prognositc signature comprising markers ME2 and FAS |
| EP2377950B1 (en) | 2006-01-11 | 2014-09-17 | Genomic Health, Inc. | Gene expression markers for colorectal cancer prognosis |
| US20100009905A1 (en) | 2006-03-24 | 2010-01-14 | Macina Roberto A | Compositions and Methods for Detection, Prognosis and Treatment of Colon Cancer |
| US20090258795A1 (en) * | 2007-03-15 | 2009-10-15 | Genomic Health, Inc. | Gene expression markers for prediction of patient response to chemotherapy |
| US8067178B2 (en) * | 2008-03-14 | 2011-11-29 | Genomic Health, Inc. | Gene expression markers for prediction of patient response to chemotherapy |
| US8765383B2 (en) * | 2009-04-07 | 2014-07-01 | Genomic Health, Inc. | Methods of predicting cancer risk using gene expression in premalignant tissue |
| EP2425020A4 (en) * | 2009-05-01 | 2016-04-20 | Genomic Health Inc | GENE EXPRESSION PROFILE ALGORITHM AND COLORECTAL CANCER RECURRENCE PROBABILITY ANALYSIS AND RESPONSE TO CHEMOTHERAPY |
-
2007
- 2007-01-11 EP EP10177406.5A patent/EP2377950B1/en not_active Not-in-force
- 2007-01-11 NZ NZ593228A patent/NZ593228A/xx unknown
- 2007-01-11 EP EP10194713A patent/EP2412820A1/en not_active Withdrawn
- 2007-01-11 KR KR1020087019544A patent/KR20090003178A/ko not_active Application Discontinuation
- 2007-01-11 NZ NZ593227A patent/NZ593227A/xx unknown
- 2007-01-11 NZ NZ593229A patent/NZ593229A/xx unknown
- 2007-01-11 EP EP10194715A patent/EP2407553A1/en not_active Withdrawn
- 2007-01-11 WO PCT/US2007/000995 patent/WO2007082099A2/en active Application Filing
- 2007-01-11 MX MX2008008973A patent/MX2008008973A/es active IP Right Grant
- 2007-01-11 EP EP10194719.0A patent/EP2412823B1/en not_active Not-in-force
- 2007-01-11 JP JP2008550454A patent/JP5297202B2/ja active Active
- 2007-01-11 EP EP10194722A patent/EP2400036A1/en not_active Withdrawn
- 2007-01-11 AU AU2007204826A patent/AU2007204826B2/en active Active
- 2007-01-11 NZ NZ593225A patent/NZ593225A/xx unknown
- 2007-01-11 CA CA002636984A patent/CA2636984A1/en not_active Abandoned
- 2007-01-11 NZ NZ593226A patent/NZ593226A/xx unknown
- 2007-01-11 NZ NZ593224A patent/NZ593224A/xx unknown
- 2007-01-11 BR BRPI0706511-6A patent/BRPI0706511A2/pt not_active IP Right Cessation
- 2007-01-11 DK DK07717900.0T patent/DK1974058T3/da active
- 2007-01-11 US US11/653,102 patent/US7695913B2/en active Active
- 2007-01-11 EP EP10194714.1A patent/EP2412821B1/en not_active Not-in-force
- 2007-01-11 NZ NZ569788A patent/NZ569788A/en unknown
- 2007-01-11 EP EP10194717A patent/EP2412822A1/en not_active Withdrawn
- 2007-01-11 EP EP10194720.8A patent/EP2412824B1/en not_active Not-in-force
- 2007-01-11 ES ES07717900.0T patent/ES2491222T3/es active Active
- 2007-01-11 EP EP07717900.0A patent/EP1974058B1/en active Active
-
2008
- 2008-07-13 IL IL192794A patent/IL192794A/en active IP Right Grant
- 2008-08-08 NO NO20083461A patent/NO20083461L/no not_active Application Discontinuation
-
2009
- 2009-01-15 HK HK09100394.3A patent/HK1120089A1/xx not_active IP Right Cessation
-
2010
- 2010-01-29 US US12/696,934 patent/US8153378B2/en active Active
- 2010-10-25 US US12/911,544 patent/US8153380B2/en active Active
- 2010-10-25 US US12/911,532 patent/US8029995B2/en active Active
- 2010-10-25 US US12/911,551 patent/US8026060B2/en active Active
- 2010-10-25 US US12/911,519 patent/US8273537B2/en active Active
- 2010-10-25 US US12/911,526 patent/US8153379B2/en active Active
-
2011
- 2011-01-19 US US13/009,733 patent/US8198024B2/en active Active
-
2012
- 2012-03-06 US US13/413,338 patent/US8367345B2/en active Active
- 2012-12-13 JP JP2012272400A patent/JP5486664B2/ja active Active
- 2012-12-28 US US13/729,462 patent/US20130102492A1/en not_active Abandoned
-
2013
- 2013-06-13 JP JP2013124952A patent/JP2013215201A/ja active Pending
- 2013-06-13 JP JP2013124951A patent/JP5486720B2/ja active Active
- 2013-06-13 JP JP2013124949A patent/JP5486718B2/ja active Active
- 2013-06-13 JP JP2013124950A patent/JP5486719B2/ja active Active
- 2013-06-13 JP JP2013124948A patent/JP5486717B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1974058T3 (da) | Genekspressionsmarkører til prognosticering af kolorektal cancer | |
| LTC2059534I2 (lt) | Genų inžinerijos būdu pagaminti anti-IL-23P19 antikūnai | |
| CY2020039I1 (el) | Νεα anti-cd38 αντισωματα για τη θεραπευτικη αγωγη καρκινου | |
| DK2115472T3 (da) | Cancerbiomarkører | |
| DK3106873T3 (da) | Fremgangsmåde til detektering af cancer | |
| DK2120579T3 (da) | Inhibitorer af poly(ADP-ripose)polymerase | |
| DK2126801T3 (da) | Fremgangsmåde til udvælgelse af information | |
| DK2325648T3 (da) | Fremgangsmåde til detektering af cancer | |
| BRPI0720226A2 (pt) | Genes marcadores selecionáveis | |
| DK2086960T3 (da) | Nye inhibitorer af glutaminylcyclase. | |
| ATE510825T1 (de) | Acylaminopyrazole als fgfr-inhibitoren | |
| DK2848610T3 (da) | Hæmmere af kinaseaktivitet | |
| DK2068927T3 (da) | Fremgangsmåder til reducering af eosinofilniveauer | |
| ATE478064T1 (de) | Als pi-3-kinaseinhibitoren verwendete pyrimidinderivate | |
| DK2504451T3 (da) | Fremgangsmåder til at forudsige det kliniske forløb af cancer | |
| BRPI0813002A2 (pt) | marcadores preditivos para o câncer ovariano | |
| DE602007011793D1 (de) | Biaryl-ether-harnstoffverbindungen | |
| DK2069312T3 (da) | Pyridazinonderivater | |
| DK2061561T3 (da) | Sammensætninger til behandling af cancer | |
| BRPI0813761A2 (pt) | Biblioteca multitarefa de programação do negócio | |
| DK2152879T3 (da) | RNA antagonistforbindelser til modulering af beta-catenin | |
| DK1844662T3 (da) | Metode til belægning af objekter | |
| DK2126602T3 (da) | Tilvejebringelse af hjælpedata | |
| BRPI0814797A2 (pt) | Inibidores dna-pk | |
| DK2111555T3 (da) | Diagnosticering af præeklampsi |